Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Bimake/Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)/1 mL x 10/B14002,Bimake,,Bimake,+,,Array.Array.Array蚂蚁淘厂家直采.
主营:分子类,蛋白类,抗体类,生化类试剂
banner
当前位置: 首页 > 产品中心 > > Bimake/Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)/1 mL x 10/B14002

Bimake/Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)/1 mL x 10/B14002

Bimake/Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)/1 mL x 10/B14002
  • Bimake/Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO)/1 mL x 10/B14002
商品介绍
  • Advantages
  • Customer Reviews
  • Price Comparison
  • Description
  • Storage
  • Protocol
  • File Download

Advantages

Customer Reviews

Product Use Citation(89)

  • Acta Pharmacol Sin, 2019, 10.1038/s41401-019-0214-z
    Autophagy, 2019, 10.1080/15548627
    J Med Genet, 2019, 10.1136/jmedgenet-2018-105936
    Int J Biol Sci, 2019, 15(3):507-521
    Am J Cancer Res, 2019, 9(3):608-618
  • Mol Biol Cell, 2019, 30(6):766-777
    Osteoarthritis Cartilage, 2019, 10.1016/j.joca.2019.02.797
    Mol Cell Proteomics, 2019, 10.1074/mcp.RA119.001457
    Cell Rep, 2019, 26(5):1273-1285
    Neuroscience, 2019, 399:117-124
  • Cell Mol Immunol, 2018, 10.1038/s41423-018-0183-z
    FASEB J, 2018, 32(10):5520-5531
    Mol Neurobiol, 2018, 10.1007/s12035-018-1445-6
    Int J Biol Sci, 2018, 15(3):507-521
    Neuroscience, 2018, 10.1016/j.neuroscience.2018.12.026
  • Exp Cell Res, 2018, 373(1-2):119-131
    PLoS One, 2018, 13(11):e0207011
    Cancer Lett, 2018, 421:161-169
    Mol Psychiatry, 2018, 10.1038/s41380-018-0086-5
    Cancer Lett, 2018, 422:56-69
  • Lab Invest, 2018, 98(8):1025-1038
    J Environ Sci (China), 2018, 69:85-94
    Mol Biol Cell, 2018, 29(2):75-83
    Exp Ther Med, 2018, 15(4):3908-3916
    Front Physiol, 2018, 9:400
  • FEBS Open Bio, 2018, 8(3):416-425
    Cell Death Dis, 2018, 9(3):277
    Biol Trace Elem Res, 2018, 184(1):47-59
    Cancer Res, 2018, 78(18):5274-5286
    Cell Signal, 2018, 52:74-82
  • J Mol Histol, 2018, 49(5):459-469
    Mol Immunol, 2018, 99:191-198
    DNA Repair (Amst), 2018, 68:12-24
    J Cell Mol Med, 2018, 10.1111/jcmm.13665
    Biochem Biophys Res Commun, 2018, 497(2):473-479
  • J Steroid Biochem Mol Biol, 2018, 181:63-72
    Int J Mol Med, 2018, 41(4):2099-2107
    Am J Physiol Endocrinol Metab, 2018, 10.1152/ajpendo.00050.2018
    Transl Oncol, 2018, 11(5):1160-1170
    Oncol Lett, 2018, 16(4):4640-4648
  • Mol Med Rep, 2018, 17(3):4490-4498
    PLoS One, 2018, 13(4):e0194728
    J Neurosci Res, 2018, 10.1002/jnr.24324
    Biochem Biophys Res Commun, 2018, 497(2):726-733
    J Virol, 2018, 10.1128/JVI.01042-18
  • Int J Mol Med, 2018, 42(2):851-860
    Exp Neurol, 2018, 308:90-99
    EBioMedicine, 2018, 27:247-257
    Cell Physiol Biochem, 2018, 48(3):880-890
    Cell Physiol Biochem, 2018, 47(1):161-175
  • Biochem Biophys Res Commun, 2018, 498(1):234-239
    Br J Nutr, 2018, 119(12):1346-1354
    Anal Chem, 2018, 10.1021/acs.analchem.8b03335
    J Exp Clin Cancer Res, 2018, 37(1):189
    J Neuroinflammation, 2018, 15(1):109
  • J Hematol Oncol, 2018, 11(1):77
    Gene, 2018, 669:35-41
    J Gastroenterol Hepatol, 2018, 10.1111/jgh.13884
    Biochem Biophys Res Commun, 2018, 501(4):1068-1073
    Cell Host Microbe, 2017, 22(1):86-98.e4
  • Oncotarget, 2017, 8(9):14708-14718
    Mutat Res, 2017, 800-802:1-7
    Cell Death Dis, 2017, 8(5):e2796
    FASEB J, 2017, 10.1096/fj.201601159RR
    Int J Cancer, 2017, 140(2):411-422
  • Appetite, 2017, 108:238-244
    Eur J Appl Physiol, 2017, 10.1007/s00421-017-3547-7
    Toxicol Lett, 2017, 265:53-60
    J Pediatr Surg, 2017, 10.1016/j.jpedsurg
    J Vis Exp, 2016, (108):53563
  • Sci Rep, 2016, 6:38946
    J Anim Sci, 2016, 94(8):3312-3320
    J Pineal Res, 2016, 61(3):317-27
    Immunobiology, 2016, 221(11):1293-303
    Arthritis Res Ther, 2016, 18(1):105
  • PLoS One, 2016, 11(2):e0148927
    Exp Biol Med (Maywood), 2016, 242(2):177-183
    Genes Dev, 2016, 30(23):2623-2636
    IUBMB Life, 2016, 68(9):764-75
    ACS Appl Mater Interfaces, 2016, 10.1021/acsami.5b10598
  • Journal of Pharmaceutical and Biomedical Analysis, 2016, 63-73
    Biochem Biophys Res Commun, 2016, 10.1016
    Toxicol Appl Pharmacol, 2016, 10.1016
    PLoS One, 2016, 11(2):e0148927
    Acta Pharmacol Sin, 2015, 36: 1–7
  • J Biol Chem,2015,10.1002/mc.22298
    Mol Med Rep,2015,12: 7403-7411
    Chem Biol,2015, 10.1016/j.chembiol.2015.09.012
    Experimental and therapeutic medicine, 2015, 10.3892//etm.2015.2871

Customer Product Validation(7)

Price Comparison

Description

Endogenous proteins are produced and removed in a balanced state, so their cellular levels are generally stable under stable environmental conditions. However, protein production is greatly halted and degradation is enhanced when cells are studied in vitro. To prevent the degradation of proteins under such conditions, one can utilize a cocktail of small molecule inhibitors to block the action of proteases.

Generally, protease inhibitor cocktails are used in mammalian cell lysates or tissue extracts to increase protein stability. As the name indicates, the cocktail functions to inhibit proteases that would degrade either phosphorylated or non-phosphorylated protein substrates

Contents

Ingredient 100x Conc. Target
AEBSF 104 mM Serine proteases
80 μM Serine proteases
Bestatin 5 mM Aminopeptidases
E-64 1.5 mM Cysteine proteases
Leupeptin 2 mM Serine and cysteine proteases
Pepstatin A 1.5 mM Aspartic proteases

Storage

The product should be stored at -20°C, and is stable for at least 2 years.

Protocol

Application Fields Western Blot analysis, Co-IP, pull-down, IF, IHC, kinase assay and etc.
Experiment Protocol Thaw at room temperature, add at 1:100 (v/v) dilution to solution samples (such as cell lysates or tissue extracts), before assaying.

Trouble Shooting

Q#1: Why to use protease inhibitor cocktail?A#1: Protease inhibitor cocktail is low-toxic agent which comprehensively protect proteins from degradation by various proteases. As the development of life science, more and more researches focus on proteins of low concentration, such as proteins in signal pathway. Precious as these low content protein, protease inhibitor cocktail offer more reliable protection than single inhibitor like PMSF.

Q#2: Could protease inhibitor cocktail be diluted more than instructed?A#2: The inhibition effects relies on many factors, such as the protein degradation tendency, the concentrations and activities of proteases, inhibitor concentrations. Bimake protease inhibitor cocktail uses classic combination of inhibitors of sufficient concentration to ensure full protection against different proteases. To achieve best protection, the products should be diluted strictly according to instructed proportion.

Q#3: PMSF is often used to protect proteins. Does protease inhibitor cocktail possess advantage over PMSF?A#3: PMSF is a traditional serine protease inhibitor, widely used inprotein purification by addition to cell lysis buffer. As PMSF have many shortages, it is gradually replaced by protease inhibitor cocktail which has better protective performance and is safer to use. To minimize the toxicity, AEBSF is chose to replace PMSF in protease inhibitor cocktail. AEBSF and PMSF have equal inhibitory efficiency but AEBSF is 14 times safer than PMSF. As LD50 of AEBSF and PMSF are 2834mg/kg and 200mg/kg, respectively. Another flaw of PMSF is that it is easy to degrade in water solution, with half-time period of 30 minutes. Protease inhibitor cocktail provides protection not only more comprehensive but also more durable.

Q#4: Tablet or solution, which kind of protease inhibitor cocktail should I choose? A#4: Some details are important when choosing which cocktail to use. Both formulas contain additives. The tablet has several pharmaceutical components which are usually proprietary and non-publicized, while the solution cocktail has DMSO as a solvent. Generally, these additives do not influence product performance. In industrial production, solutions are less processed than tablets, which results in a better quality and lower prices for solutions. On the other hand, tablets possess advantages over solutions in both storage and shipment, as tablets can be stored at 4 degrees instead of -20 degrees. We recommend solution products, as they have a lower price, more accurate inhibitor doses, and readiness to aliquot.

Q#5: Could DMSO cause problems in my experiments? A#5:The possibility that DMSO will influence experimental results is very low. DMSO is widely used as a solvent for biologically active compounds in life science experiments, including high requirement applications such as protein crystallization and CoIP. DMSO is stable at room temperature, and is a perfect cryoprotectant for cell storage in low temperatures.

Q#6: Even after using the protease inhibitor cocktail, experimental results were poor. How can this problem be improved?A#6: Bimake"s protease inhibitor cocktail can provide adequate protection for most proteins. If protein degradation remains severe with cocktail addition, carefully check the experimental protocol and procedures for optimal use of the protease inhibitor cocktail. For example, the lysis buffer system must be carefully prepared, and with the addition of protease inhibitor cocktail, the cell samples should be treated immediately after being collected or thawed.

File Download

Manual | Protease Inhibitor CocktailMSDS | Protease Inhibitor Cocktail
品牌介绍

Bimake总公司美国Bimake生物科技有限公司成立于美国德克萨斯州休斯敦。作为集研发、生产、销售于一体的全球领先的试剂公司,Bimake一直专注于生命科学领域高端试剂的开发与研究,为客户提供用于药物研发的高品质生命科学试剂。产品主要包括分子生物学、细胞生物学、蛋白以及抗体类试剂。目前Bimake在中国、欧洲、日本均设有分部,通过在中国、欧洲和美国的仓库辐射全球整个市场。

自营商城图标
厂家直采
全球直采模式 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔